Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections.
Bhavnani SM, Hammel JP, Lakota EA, Liolios K, Trang M, Rubino CM, Steenbergen JN, Friedrich L, Tzanis E, Ambrose PG. Bhavnani SM, et al. Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0128123. doi: 10.1128/aac.01281-23. Epub 2024 Jul 31. Antimicrob Agents Chemother. 2024. PMID: 39082883 Free PMC article. Clinical Trial.
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections.
Melnick D, Talley AK, Gupta VK, Critchley IA, Eckburg PB, Hamed KA, Bhatt N, Moore G, Austin D, Rubino CM, Bhavnani SM, Ambrose PG. Melnick D, et al. Among authors: bhavnani sm. Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0053523. doi: 10.1128/aac.00535-23. Epub 2023 Sep 28. Antimicrob Agents Chemother. 2023. PMID: 37768311 Free PMC article.
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
Bhavnani SM, Hammel JP, Lakota EA, Trang M, Bader JC, Bulik CC, VanScoy BD, Rubino CM, Huband MD, Friedrich L, Steenbergen JN, Ambrose PG. Bhavnani SM, et al. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0221321. doi: 10.1128/aac.02213-21. Epub 2023 Mar 22. Antimicrob Agents Chemother. 2023. PMID: 36946741 Free PMC article. Clinical Trial.
Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches.
Lepak AJ, Trang M, Hammel JP, Sader HS, Bhavnani SM, VanScoy BD, Pogue JM, Ambrose PG, Andes DR; United States Committee on Antimicrobial Susceptibility Testing. Lepak AJ, et al. Among authors: bhavnani sm. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0145222. doi: 10.1128/aac.01452-22. Epub 2023 Mar 22. Antimicrob Agents Chemother. 2023. PMID: 36946729 Free PMC article.
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.
Trang M, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Among authors: bhavnani sm. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0239721. doi: 10.1128/aac.02397-21. Epub 2023 Mar 14. Antimicrob Agents Chemother. 2023. PMID: 36916956 Free PMC article.
136 results